Randall Brauchle, MD
Otolaryngology · Houston, TXNPI 1124005350
Payments from drug & device makers
Across 82 payments — averaging $56.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acclarent, Inc$793
- Medtronic$669
- Stryker$511
- Integra Lifesciences Corporation$372
- Optinose US, Inc.$359
- Sanofi$300
- plus $2K from 16 others
What the payments were for
- Travel & lodging$90%
- Food & beverage$4,605100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acclarent, Inc | 10 | $793 |
| Medtronic(2 entities) | 13 | $669 |
| Stryker | 4 | $511 |
| Integra Lifesciences Corporation | 5 | $372 |
| Optinose US, Inc. | 8 | $359 |
| Sanofi | 7 | $300 |
| GSK | 5 | $225 |
| Neurent Medical Limited | 3 | $216 |
| Regeneron Healthcare Solutions, Inc. | 3 | $176 |
| Hologic Sales And Service, LLC | 1 | $148 |
| Merck | 4 | $140 |
| Aerin Medical Inc. | 2 | $137 |
| Inspire Medical Systems, Inc. | 2 | $137 |
| Intersect ENT, Inc. | 1 | $118 |
| Olympus America Inc. | 2 | $99 |
| Novartis | 5 | $82 |
| Boston Scientific | 2 | $51 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| AstraZeneca | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| 3b Medical, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acclarent Aera$564
- SCOUT$347
- Inspira Air$310
- TruDi Probe$310
- PROPEL$231
- NEUROMARK System$164
- NEUROMARK Radiofrequency Console$164
- AUDION ET DILATION SYSTEM$149
- CoolSeal Generator$148
- XPRESS ENT DILATION SYSTEM$144
- RELIEVA SPINPLUS NAV$137
- Inspire Upper Airway Stimulation System$134
- NUCALA$125
- TruDi Nav Cable$123
- Relieva Spinplus$123
- NUVENT$121
- FUSION$119
- Xhance$115
- SINUVA$113
- DUPIXENT$110
How this compares
$4,614 in reported general payments places this provider in the 70th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Epinephrine | 29 | $4,065 |
| Ipratropium Bromide | 120 | $3,423 |
| Azelastine Hcl | 116 | $3,152 |
| Levocetirizine Dihydrochloride | 70 | $1,898 |
| CefuroximeCefuroxime Axetil | 90 | $1,464 |
| Olopatadine Hcl | 12 | $929 |
| Ofloxacin | 44 | $830 |
| Mupirocin | 60 | $662 |
| Doxycycline Monohydrate | 21 | $295 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $278 |
| Levofloxacin | 44 | $246 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $238 |
| Montelukast Sodium | 31 | $232 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $177 |
| Prednisone | 44 | $155 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USAEpinephrine | $17 | $4,06529 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 729 otolaryngology providers in Texas.
Other otolaryngology in Houston
- Mark ZafereoHouston$7.8M
- Neil GrossHouston$1.5M
- Stephen LaiHouston$968K
- Amber LuongHouston$793K
- Masayoshi TakashimaHouston$644K
- Arjuna KuperanHouston$348K
- Ron KarniHouston$336K
- William YaoHouston$280K
- Martin CitardiHouston$264K
- Michael KaplanHouston$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.